With a market cap of $7.5 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, ...

ImmunityBio's stock is moving higher after the FDA announced it would review a possible label expansion for the company's ...

Interim data from that trial suggested that PBFT02 may slow disease progression in patients with frontotemporal dementia.

ARLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- KALA BIO , Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock, ...

BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has approved a 1-for-10 reverse ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

Bluebird Bio has launched three gene-editing therapies. These treatments are expensive and complex to administer, and they face stiff competition. Though Bluebird Bio is an innovative biotech, the ...

TELA Bio TELA shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share. What Happened: On Tuesday after market closure, TELA Bio announced a public offering ...

If a little bird told you to think about buying Bluebird Bio (NASDAQ: BLUE) stock recently, there's a lot of information you'll need to evaluate. Between the new product that this small biotech has ...